Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Paton

Showing results (111-120 of 624) with videos related to

Pageof 63
Sort By:
Infection and Immunity|November 1, 1984
Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysinA Ferrante, B Rowan-Kelly, J C Paton
Trends in Molecular Medicine|June 23, 2012
Bioengineered microbes in disease therapyAdrienne W Paton, Renato Morona, James C Paton
Journal of Clinical Microbiology|July 17, 1998
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolatesJ M Bell, J C Paton, J Turnidge
Microbial Pathogenesis|January 1, 1988
Purification and immunological characterization of neuraminidase produced by Streptococcus pneumoniaeR A Lock, J C Paton, D Hansman
European Journal of Cancer Care|June 15, 2005
Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelinesR McCoubrie, D Jeffrey, C Paton, et al.
Microbial Pathogenesis|February 1, 1992
Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniaeR A Lock, D Hansman, J C Paton
Infection and Immunity|February 17, 2001
Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraoseA W Paton, R Morona, J C Paton
Microbial Pathogenesis|December 1, 1988
Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniaeR A Lock, J C Paton, D Hansman
Infection and Immunity|June 3, 2009
Sab, a novel autotransporter of locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli O113:H21, contributes to adherence and biofilm formationSylvia Herold, James C Paton, Adrienne W Paton
Annals of the New York Academy of Sciences|December 27, 1996
Biochemical findings in a series of Australian patients with isolated defects in peroxisomal beta-oxidationB C Paton, P C Sharp, A Poulos
Pageof 63

Showing results (111-120 of 624) with videos related to

Sort By:
Pageof 63
Infection and Immunity|November 1, 1984
Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysinA Ferrante, B Rowan-Kelly, J C Paton
Trends in Molecular Medicine|June 23, 2012
Bioengineered microbes in disease therapyAdrienne W Paton, Renato Morona, James C Paton
Journal of Clinical Microbiology|July 17, 1998
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolatesJ M Bell, J C Paton, J Turnidge
Microbial Pathogenesis|January 1, 1988
Purification and immunological characterization of neuraminidase produced by Streptococcus pneumoniaeR A Lock, J C Paton, D Hansman
European Journal of Cancer Care|June 15, 2005
Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelinesR McCoubrie, D Jeffrey, C Paton, et al.
Microbial Pathogenesis|February 1, 1992
Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniaeR A Lock, D Hansman, J C Paton
Infection and Immunity|February 17, 2001
Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraoseA W Paton, R Morona, J C Paton
Microbial Pathogenesis|December 1, 1988
Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniaeR A Lock, J C Paton, D Hansman
Infection and Immunity|June 3, 2009
Sab, a novel autotransporter of locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli O113:H21, contributes to adherence and biofilm formationSylvia Herold, James C Paton, Adrienne W Paton
Annals of the New York Academy of Sciences|December 27, 1996
Biochemical findings in a series of Australian patients with isolated defects in peroxisomal beta-oxidationB C Paton, P C Sharp, A Poulos
Pageof 63